- Home
- NGS vs OCGN Comparison
NGS vs OCGN Comparison
Compare NGS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- OCGN
- Stock Information
- Founded
- NGS 1998
- OCGN 2013
- Country
- NGS United States
- OCGN United States
- Employees
- NGS N/A
- OCGN N/A
- Industry
- NGS Oilfield Services/Equipment
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NGS Energy
- OCGN Health Care
- Exchange
- NGS Nasdaq
- OCGN Nasdaq
- Market Cap
- NGS 241.7M
- OCGN 246.8M
- IPO Year
- NGS 2002
- OCGN N/A
- Fundamental
- Price
- NGS $27.73
- OCGN $0.89
- Analyst Decision
- NGS Strong Buy
- OCGN Strong Buy
- Analyst Count
- NGS 2
- OCGN 3
- Target Price
- NGS $26.50
- OCGN $5.67
- AVG Volume (30 Days)
- NGS 78.0K
- OCGN 6.1M
- Earning Date
- NGS 11-14-2024
- OCGN 11-08-2024
- Dividend Yield
- NGS N/A
- OCGN N/A
- EPS Growth
- NGS 605.21
- OCGN N/A
- EPS
- NGS 1.28
- OCGN N/A
- Revenue
- NGS $152,305,000.00
- OCGN $4,700,000.00
- Revenue This Year
- NGS $30.81
- OCGN N/A
- Revenue Next Year
- NGS $13.48
- OCGN N/A
- P/E Ratio
- NGS $21.65
- OCGN N/A
- Revenue Growth
- NGS 41.72
- OCGN N/A
- 52 Week Low
- NGS $13.70
- OCGN $0.49
- 52 Week High
- NGS $28.50
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- NGS 61.67
- OCGN 54.92
- Support Level
- NGS $25.17
- OCGN $0.79
- Resistance Level
- NGS $26.08
- OCGN $0.88
- Average True Range (ATR)
- NGS 1.27
- OCGN 0.08
- MACD
- NGS 0.14
- OCGN 0.01
- Stochastic Oscillator
- NGS 89.49
- OCGN 65.97
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").